Skip to main content
SpringerLink
Log in

Vestibular Migraine

  • Chapter
  • First Online:
Disorders of the Vestibular System

  • 404 Accesses

Abstract

Despite its relatively recent widespread recognition, vestibular migraine is one of the most common causes of dizziness and vertigo in the world. It’s far more common than other better known causes of vertigo, such as Meniere’s disease. Study of vestibular migraine has been hampered by a lack of knowledge regarding pathophysiology, diagnosis, and treatment effectiveness. In addition, inefficient care models, high rates of comorbid anxiety, difficulty with symptom description, lack of biomarkers, and historical misogyny in medicine may have all contributed to underrecognition and undertreatment. However, recent years have seen increased attention from relevant practitioners, including otolaryngologists, neurologists, researchers, audiologists, and physical therapists. While much work needs to be done, progress is being made. In this chapter, we will provide a detailed picture of the current knowledge of vestibular migraine.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bickerstaff ER. Impairment of consciousness in migraine. Lancet. 1961;2:1057–9.

    Article  CAS  PubMed  Google Scholar 

  2. Boenheim F. Über familiare Hemicrania vestibularis. Neurol Zentralbl. 1917;36:226–9.

    Google Scholar 

  3. Heveroch J. La migraine vestibulaire. Rev Neurol. 1925;33:925–9.

    Google Scholar 

  4. Symonds CP. Vertigo. Postgrad Med J. 1926;1:63–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Richter H. Die Migräne. In: Epilepsie · Narkolepsie Spasmophilie · Migräne Vasomotorisch-Trophische Erkrankungen Neurasthenische Reaktion Organneurosen; 1935. p. 166–245. https://doi.org/10.1007/978-3-662-28772-9_2.

    Chapter  Google Scholar 

  6. Levy I, O’Leary JL. LI incidence of vertigo in neurological conditions. Ann Otol Rhinol Laryngol. 1947;56:557–75.

    Article  CAS  PubMed  Google Scholar 

  7. Friedman AP, Von Storch TJ, Merritt HH. Migraine and tension headaches; a clinical study of two thousand cases. Neurology. 1954;4:773–88.

    Article  CAS  PubMed  Google Scholar 

  8. Selby G, Lance JW. Observations on 500 cases of migraine and allied vascular headache. J Neurol Neurosurg Psychiatry. 1960;23:23–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Kayan A, Derrick Hood J. Neuro-otological manifestations of migraine. Brain. 1984;107:1123–42.

    Article  PubMed  Google Scholar 

  10. Cutrer FM, Baloh RW. Migraine-associated dizziness. Headache. 1992;32:300–4.

    Article  CAS  PubMed  Google Scholar 

  11. Savundra PA, Carroll JD, Davies RA, Luxon LM. Migraine-associated vertigo. Cephalalgia. 1997;17:505–10; discussion 487.

    Article  CAS  PubMed  Google Scholar 

  12. Cass SP, et al. Migraine-related vestibulopathy. Ann Otol Rhinol Laryngol. 1997;106:182–9.

    Article  CAS  PubMed  Google Scholar 

  13. Dieterich M, Brandt T. Episodic vertigo related to migraine (90 cases): vestibular migraine? J Neurol. 1999;246:883–92.

    Article  CAS  PubMed  Google Scholar 

  14. Khomov IA, Koksharova NV. Extractive and photometric quantitative determination of promedol. Farmatsiia. 1975;24:76–7.

    CAS  PubMed  Google Scholar 

  15. Lempert T, et al. Vestibular migraine: diagnostic criteria: consensus document of the Bárány Society and the International Headache Society. Nervenarzt. 2013;84:511–6.

    Article  CAS  PubMed  Google Scholar 

  16. Dodick DW. Migraine. Lancet. 2018;391:1315–30.

    Article  PubMed  Google Scholar 

  17. Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38:1–211.

    Article  Google Scholar 

  18. Neuhauser H, Leopold M, von Brevern M, Arnold G, Lempert T. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology. 2001;56:436–41.

    Article  CAS  PubMed  Google Scholar 

  19. Lempert T, Neuhauser H. Epidemiology of vertigo, migraine and vestibular migraine. J Neurol. 2009;256:333–8.

    Article  PubMed  Google Scholar 

  20. Formeister EJ, Rizk HG, Kohn MA, Sharon JD. The epidemiology of vestibular migraine: a population-based survey study. Otol Neurotol. 2018;39:1037–44.

    Article  PubMed  Google Scholar 

  21. Colombo B, Teggi R, NIVE Project. Vestibular migraine: who is the patient? Neurol Sci. 2017;38:107–10.

    Article  PubMed  Google Scholar 

  22. Elixhauser A. Hospital inpatient statistics, 1996: tools for decisionmaking & research; 1999.

    Google Scholar 

  23. Kroenke K, Mangelsdorff AD. Common symptoms in ambulatory care: incidence, evaluation, therapy, and outcome. Am J Med. 1989;86:262–6.

    Article  CAS  PubMed  Google Scholar 

  24. Ruthberg JS, Rasendran C, Kocharyan A, Mowry SE, Otteson TD. The economic burden of vertigo and dizziness in the United States. J Vestib Res. 2021;31:81–90.

    Article  PubMed  Google Scholar 

  25. Saber Tehrani AS, et al. Rising annual costs of dizziness presentations to U.S. emergency departments. Acad Emerg Med. 2013;20:689–96.

    Article  PubMed  Google Scholar 

  26. Kovacs E, Wang X, Grill E. Economic burden of vertigo: a systematic review. Health Econ Rev. 2019;9:37.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Agrawal Y, Carey JP, Della Santina CC, Schubert MC, Minor LB. Disorders of balance and vestibular function in US adults: data from the National Health and Nutrition Examination Survey, 2001–2004. Arch Intern Med. 2009;169:938–44.

    Article  PubMed  Google Scholar 

  28. Lasisi AO, Gureje O. Disability and quality of life among community elderly with dizziness: report from the Ibadan study of ageing. J Laryngol Otol. 2010;124:957–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Shah DR, Dilwali S, Friedman DI. Migraine Aura without headache [corrected]. Curr Pain Headache Rep. 2018;22:77.

    Article  PubMed  Google Scholar 

  30. Kumar A, Samanta D, Emmady PD, Arora R. Hemiplegic migraine. In: StatPearls. StatPearls Publishing; 2020.

    Google Scholar 

  31. Kadian R, Shankar Kikkeri N, Kumar A. Basilar migraine. In: StatPearls. StatPearls Publishing; 2020.

    Google Scholar 

  32. Winner P. Abdominal migraine. Semin Pediatr Neurol. 2016;23:11–3.

    Article  PubMed  Google Scholar 

  33. Bhandari S, et al. Cyclic vomiting syndrome: epidemiology, diagnosis, and treatment. Clin Auton Res. 2018;28:203–9.

    Article  PubMed  Google Scholar 

  34. Lee JD, et al. Prevalence of vestibular and balance disorders in children and adolescents according to age: a multi-center study. Int J Pediatr Otorhinolaryngol. 2017;94:36–9.

    Article  PubMed  Google Scholar 

  35. Deonna T, Martin D. Benign paroxysmal torticollis in infancy. Arch Dis Child. 1981;56:956–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Baloh RW. Neurotology of migraine. Headache. 1997;37:615–21.

    Article  CAS  PubMed  Google Scholar 

  37. Basser LS. Benign paroxysmal vertigo of childhood. (A variety of vestibular neuronitis). Brain. 1964;87:141–52.

    Article  CAS  PubMed  Google Scholar 

  38. Fenichel GM. Migraine as a cause of benign paroxysmal vertigo of childhood. J Pediatr. 1967;71:114–5.

    Article  CAS  PubMed  Google Scholar 

  39. Lindskog U, Odkvist L, Noaksson L, Wallquist J. Benign paroxysmal vertigo in childhood: a long-term follow-up. Headache. 1999;39:33–7.

    Article  CAS  PubMed  Google Scholar 

  40. Godley FA, Casiano RR, Mehle M, McGeeney B, Gottschalk C. Update on the diagnostic considerations for neurogenic nasal and sinus symptoms: a current review suggests adding a possible diagnosis of migraine. Am J Otolaryngol. 2019;40:306–11.

    Article  PubMed  Google Scholar 

  41. Eross E, Dodick D, Eross M. The Sinus, Allergy and Migraine Study (SAMS). Headache. 2007;47:213–24.

    Article  PubMed  Google Scholar 

  42. Kari E, DelGaudio JM. Treatment of sinus headache as migraine: the diagnostic utility of triptans. Laryngoscope. 2008;118:2235–9.

    Article  CAS  PubMed  Google Scholar 

  43. Uneri A. Migraine and benign paroxysmal positional vertigo: an outcome study of 476 patients. Ear Nose Throat J. 2004;83:814–5.

    Article  PubMed  Google Scholar 

  44. Lee H, Lopez I, Ishiyama A, Baloh RW. Can migraine damage the inner ear? Arch Neurol. 2000;57:1631–4.

    Article  CAS  PubMed  Google Scholar 

  45. https://medicine.osu.edu/-/media/files/medicine/departments/otolaryngology/education/vestibular/vor-abstracts-2021-final.pdf. PMID: 36168362

  46. Neff BA, et al. Auditory and vestibular symptoms and chronic subjective dizziness in patients with Ménière’s disease, vestibular migraine, and Ménière’s disease with concomitant vestibular migraine. Otol Neurotol. 2012;33:1235–44.

    Article  PubMed  Google Scholar 

  47. Lucieer F, et al. Bilateral vestibular hypofunction: insights in etiologies, clinical subtypes, and diagnostics. Front Neurol. 2016;7:26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Pietrobon D. Calcium channels and migraine. Biochim Biophys Acta. 2013;1828:1655–65.

    Article  CAS  PubMed  Google Scholar 

  49. Espinosa-Sanchez JM, Lopez-Escamez JA. New insights into pathophysiology of vestibular migraine. Front Neurol. 2015;6:12.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Close LN, Eftekhari S, Wang M, Charles AC, Russo AF. Cortical spreading depression as a site of origin for migraine: role of CGRP. Cephalalgia. 2019;39:428–34.

    Article  PubMed  Google Scholar 

  51. Vass Z, Shore SE, Nuttall AL, Miller JM. Direct evidence of trigeminal innervation of the cochlear blood vessels. Neuroscience. 1998;84:559–67.

    Article  CAS  PubMed  Google Scholar 

  52. Vass Z, et al. Co-localization of the vanilloid capsaicin receptor and substance P in sensory nerve fibers innervating cochlear and vertebro-basilar arteries. Neuroscience. 2004;124:919–27.

    Article  CAS  PubMed  Google Scholar 

  53. Pietrobon D, Moskowitz MA. Pathophysiology of migraine. Annu Rev Physiol. 2013;75:365–91.

    Article  CAS  PubMed  Google Scholar 

  54. Hansen JM, Hauge AW, Olesen J, Ashina M. Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura. Cephalalgia. 2010;30:1179–86.

    Article  PubMed  Google Scholar 

  55. Cutrer FM, Mathew P. Calcitonin gene related peptide (CGRP)-provoked migraine-like attacks. Cephalalgia. 2010;30:1155–6.

    Article  PubMed  Google Scholar 

  56. Pellesi L, Guerzoni S, Pini LA. Spotlight on anti-CGRP monoclonal antibodies in migraine: the clinical evidence to date. Clin Pharmacol Drug Dev. 2017;6:534–47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Tanaka M, et al. Localization of calcitonin gene-related peptide in the vestibular end-organs in the rat: an immunohistochemical study. Brain Res. 1988;447:175–7.

    Article  CAS  PubMed  Google Scholar 

  58. Tanaka M, et al. Localization, origin and fine structure of calcitonin gene-related peptide-containing fibers in the vestibular end-organs of the rat. Brain Res. 1989;504:31–5.

    Article  CAS  PubMed  Google Scholar 

  59. Wackym PA, Popper P, Micevych PE. Distribution of calcitonin gene-related peptide mRNA and immunoreactivity in the rat central and peripheral vestibular system. Acta Otolaryngol. 1993;113:601–8.

    Article  CAS  PubMed  Google Scholar 

  60. Usami S, Matsubara A, Shinkawa H, Matsunaga T, Kanzaki J. Neuroactive substances in the human vestibular end organs. Acta Otolaryngol Suppl. 1995;520(Pt 1):160–3.

    Article  PubMed  Google Scholar 

  61. Popper P, Ishiyama A, Lopez I, Wackym PA. Calcitonin gene-related peptide and choline acetyltransferase colocalization in the human vestibular periphery. Audiol Neurootol. 2002;7:298–302.

    Article  CAS  PubMed  Google Scholar 

  62. Ohno K, Takeda N, Tanaka-Tsuji M, Matsunaga T. Calcitonin gene-related peptide in the efferent system of the inner ear. A review. Acta Otolaryngol Suppl. 1993;501:16–20.

    Article  CAS  PubMed  Google Scholar 

  63. Lysakowski A, Goldberg JM. Morphophysiology of the vestibular periphery. In: The vestibular system. Springer. p. 57–152. https://doi.org/10.1007/0-387-21567-0_3.

  64. Xiaocheng W, et al. The expression of calcitonin gene-related peptide and acetylcholine in the vestibular-related nucleus population of wild-type mice and retinal degeneration fast mice after rotary stimulation. J Mol Neurosci. 2013;51:514–21.

    Article  PubMed  Google Scholar 

  65. Mason BN, et al. Vascular actions of peripheral CGRP in migraine-like photophobia in mice. Cephalalgia. 2020;40:1585–604.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Maison SF, Emeson RB, Adams JC, Luebke AE, Liberman MC. Loss of alpha CGRP reduces sound-evoked activity in the cochlear nerve. J Neurophysiol. 2003;90:2941–9.

    Article  CAS  PubMed  Google Scholar 

  67. Luebke AE, et al. Loss of α-calcitonin gene-related peptide (αCGRP) reduces the efficacy of the Vestibulo-ocular reflex (VOR). J Neurosci. 2014;34:10453–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Jones SM, et al. Loss of α-calcitonin gene-related peptide (αCGRP) reduces otolith activation timing dynamics and impairs balance. Front Mol Neurosci. 2018;11:289.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Tedeschi G, Russo A, Conte F, Laura M, Tessitore A. Vestibular migraine pathophysiology: insights from structural and functional neuroimaging. Neurol Sci. 2015;36(Suppl 1):37–40.

    Article  PubMed  Google Scholar 

  70. Lopez C, Blanke O. The thalamocortical vestibular system in animals and humans. Brain Res Rev. 2011;67:119–46.

    Article  PubMed  Google Scholar 

  71. Russo A, et al. Abnormal thalamic function in patients with vestibular migraine. Neurology. 2014;82:2120–6.

    Article  PubMed  Google Scholar 

  72. Winnick A, Sadeghpour S, Otero-Millan J, Chang T-P, Kheradmand A. Errors of upright perception in patients with vestibular migraine. Front Neurol. 2018;9:892.

    Article  PubMed  PubMed Central  Google Scholar 

  73. King S, et al. Self-motion perception is sensitized in vestibular migraine: pathophysiologic and clinical implications. Sci Rep. 2019;9:14323.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Shin JH, Kim YK, Kim H-J, Kim J-S. Altered brain metabolism in vestibular migraine: comparison of interictal and ictal findings. Cephalalgia. 2014;34:58–67.

    Article  PubMed  Google Scholar 

  75. Hougaard A, Amin FM, Ashina M. Migraine and structural abnormalities in the brain. Curr Opin Neurol. 2014;27:309–14.

    Article  PubMed  Google Scholar 

  76. Cha Y-H, Kane MJ, Baloh RW. Familial clustering of migraine, episodic vertigo, and Ménière’s disease. Otol Neurotol. 2008;29:93–6.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Rudkjobing LA, Esserlind A-L, Olesen J. Future possibilities in migraine genetics. J Headache Pain. 2012;13:505–11.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Russell MB, Ducros A. Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol. 2011;10:457–70.

    Article  PubMed  Google Scholar 

  79. Ducros A, et al. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med. 2001;345:17–24.

    Article  CAS  PubMed  Google Scholar 

  80. De Fusco M, et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet. 2003;33:192–6.

    Article  PubMed  Google Scholar 

  81. Dichgans M, et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet. 2005;366:371–7.

    Article  CAS  PubMed  Google Scholar 

  82. Furman JM, Marcus DA, Balaban CD. Vestibular migraine: clinical aspects and pathophysiology. Lancet Neurol. 2013;12:706–15.

    Article  CAS  PubMed  Google Scholar 

  83. von Brevern M, et al. Migrainous vertigo: mutation analysis of the candidate genes CACNA1A, ATP1A2, SCN1A, and CACNB4. Headache. 2006;46:1136–41.

    Article  Google Scholar 

  84. Oh S-K, et al. A missense variant of the ATP1A2 gene is associated with a novel phenotype of progressive sensorineural hearing loss associated with migraine. Eur J Hum Genet. 2015;23:639–45.

    Article  CAS  PubMed  Google Scholar 

  85. Bisdorff A. Vestibular symptoms and history taking. Handb Clin Neurol. 2016;137:83–90.

    Article  CAS  PubMed  Google Scholar 

  86. Young AS, et al. Capturing acute vertigo: a vestibular event monitor. Neurology. 2019;92:e2743–53.

    Article  PubMed  Google Scholar 

  87. Weinreich HM, Carey JP. Prevalence of pulsatile tinnitus among patients with migraine. Otol Neurotol. 2016;37:244–7.

    Article  PubMed  Google Scholar 

  88. Rizk HG, et al. Cross-sectional analysis of cognitive dysfunction in patients with vestibular disorders. Ear Hear. 2020;41:1020–7.

    Article  PubMed  Google Scholar 

  89. Chari DA, Liu Y-H, Chung JJ, Rauch SD. Subjective cognitive symptoms and Dizziness Handicap Inventory (DHI) performance in patients with vestibular migraine and Menière’s disease. Otol Neurotol. 2021;42:883. https://doi.org/10.1097/MAO.0000000000003081.

    Article  PubMed  Google Scholar 

  90. Liu YF, et al. Quantification of cognitive dysfunction in dizzy patients using the Neuropsychological Vertigo Inventory. Otol Neurotol. 2019;40:e723–31.

    Article  PubMed  Google Scholar 

  91. Zhang Y, et al. International classification of headache disorders 3rd edition beta-based field testing of vestibular migraine in China: demographic, clinical characteristics, audiometric findings and diagnosis statues. Cephalalgia. 2016;36:240–8.

    Article  PubMed  Google Scholar 

  92. Chiao W, Krauter R, Kirk L, Steenerson K, Pasquesi L, Sharon J. Understanding dizzy patients a cross-sectional analysis of attitudes toward diagnosis, providers, and treatment. Ann Otol Rhinol Laryngol. 2022;131(4):352–9. https://doi.org/10.1177/00034894211022095. Epub 2021 Jun 4.

  93. Schwedt TJ. Chronic migraine. BMJ. 2014;348:g1416.

    Article  PubMed  Google Scholar 

  94. Huang T-C, Wang S-J, Kheradmand A. Vestibular migraine: an update on current understanding and future directions. Cephalalgia. 2020;40:107–21.

    Article  PubMed  Google Scholar 

  95. Lempert T, Neuhauser H. Vertigo as a symptom of migraine. Med Klin. 2001;96:475–9.

    Article  CAS  Google Scholar 

  96. Lempert T, et al. Vestibular migraine: diagnostic criteria. J Vestib Res. 2012;22:167–72.

    Article  PubMed  Google Scholar 

  97. Furman JM, Marcus DA, Balaban CD. Migrainous vertigo: development of a pathogenetic model and structured diagnostic interview. Curr Opin Neurol. 2003;16:5–13.

    Article  PubMed  Google Scholar 

  98. Vitkovic J, Paine M, Rance G. Neuro-otological findings in patients with migraine- and nonmigraine-related dizziness. Audiol Neurootol. 2008;13:113–22.

    Article  PubMed  Google Scholar 

  99. Celebisoy N, Gökçay F, Sirin H, Biçak N. Migrainous vertigo: clinical, oculographic and posturographic findings. Cephalalgia. 2008;28:72–7.

    Article  CAS  PubMed  Google Scholar 

  100. Teggi R, et al. Migrainous vertigo: results of caloric testing and stabilometric findings. Headache. 2009;49:435–44.

    Article  PubMed  Google Scholar 

  101. Boldingh MI, Ljøstad U, Mygland A, Monstad P. Vestibular sensitivity in vestibular migraine: VEMPs and motion sickness susceptibility. Cephalalgia. 2011;31:1211–9.

    Article  PubMed  Google Scholar 

  102. Baier B, Stieber N, Dieterich M. Vestibular-evoked myogenic potentials in vestibular migraine. J Neurol. 2009;256:1447–54.

    Article  PubMed  Google Scholar 

  103. Arriaga MA, Chen DA, Hillman TA, Kunschner L, Arriaga RY. Visually enhanced vestibulo-ocular reflex: a diagnostic tool for migraine vestibulopathy. Laryngoscope. 2006;116:1577–9.

    Article  PubMed  Google Scholar 

  104. Jacobson GP, Newman CW. The development of the Dizziness Handicap Inventory. Arch Otolaryngol Head Neck Surg. 1990;116:424–7.

    Article  CAS  PubMed  Google Scholar 

  105. Sharon JD, et al. Development and validation of VM-PATHI: vestibular migraine Patient Assessment Tool and Handicap Inventory. Otol Neurotol. 2020;41:e494–500.

    Article  PubMed  Google Scholar 

  106. Polensek SH, Tusa RJ. Nystagmus during attacks of vestibular migraine: an aid in diagnosis. Audiol Neurootol. 2010;15:241–6.

    Article  PubMed  Google Scholar 

  107. Eggers SDZ, Neff BA, Shepard NT, Staab JP. Comorbidities in vestibular migraine. J Vestib Res. 2014;24:387–95.

    Article  PubMed  Google Scholar 

  108. Chu C-H, Liu C-J, Lin L-Y, Chen T-J, Wang S-J. Migraine is associated with an increased risk for benign paroxysmal positional vertigo: a nationwide population-based study. J Headache Pain. 2015;16:62.

    Article  PubMed  PubMed Central  Google Scholar 

  109. Radtke A, von Brevern M, Neuhauser H, Hottenrott T, Lempert T. Vestibular migraine: long-term follow-up of clinical symptoms and vestibulo-cochlear findings. Neurology. 2012;79:1607–14.

    Article  PubMed  Google Scholar 

  110. Radtke A, et al. Migraine and Ménière’s disease: is there a link? Neurology. 2002;59:1700–4.

    Article  CAS  PubMed  Google Scholar 

  111. Brandt T, Strupp M, Dieterich M. Vestibular paroxysmia: a treatable neurovascular cross-compression syndrome. J Neurol. 2016;263(Suppl 1):S90–6.

    Article  PubMed  Google Scholar 

  112. Bi WL, et al. Superior semicircular canal dehiscence syndrome. J Neurosurg. 2017;127:1268–76.

    Article  PubMed  Google Scholar 

  113. Mau C, et al. Superior semicircular canal dehiscence: diagnosis and management. J Clin Neurosci. 2018;48:58–65.

    Article  PubMed  Google Scholar 

  114. Niesten MEF, McKenna MJ, Grolman W, Lee DJ. Clinical factors associated with prolonged recovery after superior canal dehiscence surgery. Otol Neurotol. 2012;33:824–31.

    Article  PubMed  Google Scholar 

  115. Cha Y-H, Brodsky J, Ishiyama G, Sabatti C, Baloh RW. Clinical features and associated syndromes of mal de debarquement. J Neurol. 2008;255:1038–44.

    Article  PubMed  PubMed Central  Google Scholar 

  116. Van Ombergen A, Van Rompaey V, Maes LK, Van de Heyning PH, Wuyts FL. Mal de debarquement syndrome: a systematic review. J Neurol. 2016;263:843–54.

    Article  PubMed  Google Scholar 

  117. Ghavami Y, et al. Management of mal de debarquement syndrome as vestibular migraines. Laryngoscope. 2017;127:1670–5.

    Article  PubMed  Google Scholar 

  118. Staab JP, et al. Diagnostic criteria for persistent postural-perceptual dizziness (PPPD): consensus document of the committee for the Classification of Vestibular Disorders of the Bárány Society. J Vestib Res. 2017;27:191–208.

    Article  PubMed  PubMed Central  Google Scholar 

  119. Dieterich M, Staab JP. Functional dizziness: from phobic postural vertigo and chronic subjective dizziness to persistent postural-perceptual dizziness. Curr Opin Neurol. 2017;30:107–13.

    Article  PubMed  Google Scholar 

  120. Chae R, Barber J, Temkin NR, Sharon JD, TRACK-TBI Investigators. Dizziness after traumatic brain injury: a prospective TRACK-TBI analysis of risk factors, quality of life, and neurocognitive effects. Otol Neurotol. 2022;43(10):e1148–56.

    Article  PubMed  Google Scholar 

  121. von Luckner A, Riederer F. Magnesium in migraine prophylaxis-is there an evidence-based rationale? A systematic review. Headache. 2018;58:199–209.

    Article  Google Scholar 

  122. Loder E, Burch R, Rizzoli P. The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines. Headache. 2012;52:930–45.

    Article  PubMed  Google Scholar 

  123. Reploeg MD, Goebel JA. Migraine-associated dizziness: patient characteristics and management options. Otol Neurotol. 2002;23:364–71.

    Article  PubMed  Google Scholar 

  124. Mikulec AA, Faraji F, Kinsella LJ. Evaluation of the efficacy of caffeine cessation, nortriptyline, and topiramate therapy in vestibular migraine and complex dizziness of unknown etiology. Am J Otolaryngol. 2012;33:121–7.

    Article  CAS  PubMed  Google Scholar 

  125. Lepcha A, Amalanathan S, Augustine AM, Tyagi AK, Balraj A. Flunarizine in the prophylaxis of migrainous vertigo: a randomized controlled trial. Eur Arch Otorhinolaryngol. 2014;271:2931–6.

    Article  PubMed  Google Scholar 

  126. Salviz M, Yuce T, Acar H, Karatas A, Acikalin RM. Propranolol and venlafaxine for vestibular migraine prophylaxis: a randomized controlled trial. Laryngoscope. 2016;126:169–74.

    Article  CAS  PubMed  Google Scholar 

  127. Neuhauser H, Radtke A, von Brevern M, Lempert T. Zolmitriptan for treatment of migrainous vertigo: a pilot randomized placebo-controlled trial. Neurology. 2003;60:882–3.

    Article  CAS  PubMed  Google Scholar 

  128. Bikhazi P, Jackson C, Ruckenstein MJ. Efficacy of antimigrainous therapy in the treatment of migraine-associated dizziness. Am J Otol. 1997;18:350–4.

    CAS  PubMed  Google Scholar 

  129. Cassano D, Pizza V, Busillo V. P074. Almotriptan in the acute treatment of vestibular migraine: a retrospective study. J Headache Pain. 2015;16:A114.

    Article  PubMed  PubMed Central  Google Scholar 

  130. Marcus DA, Furman JM. Prevention of motion sickness with rizatriptan: a double-blind, placebo-controlled pilot study. Med Sci Monit. 2006;12:PI1–7.

    CAS  PubMed  Google Scholar 

  131. Prakash S, Shah ND. Migrainous vertigo responsive to intravenous methylprednisolone: case reports. Headache. 2009;49:1235–9.

    Article  PubMed  Google Scholar 

  132. Maldonado Fernández M, et al. Pharmacological agents for the prevention of vestibular migraine. Cochrane Database Syst Rev. 2015;2015(6):CD010600.

    PubMed  PubMed Central  Google Scholar 

  133. Bayer O, et al. Results and lessons learnt from a randomized controlled trial: prophylactic treatment of vestibular migraine with metoprolol (PROVEMIG). Trials. 2019;20:813.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otolaryngology/Head and Neck Surgery, University of California, San Francisco, CA, USA

    Danielle M. Gillard & Jeffrey D. Sharon

Authors
  1. Danielle M. Gillard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeffrey D. Sharon
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Otolaryngology, University of Rochester, Rochester, NY, USA

    Benjamin T. Crane

  2. Department of Otolaryngology, Columbia University, New York, NY, USA

    Lawrence Lustig

  3. Department of Otolaryngology, Lilavati Hospital, Mumbai, Maharashtra, India

    Christopher de Souza

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gillard, D.M., Sharon, J.D. (2023). Vestibular Migraine. In: Crane, B.T., Lustig, L., de Souza, C. (eds) Disorders of the Vestibular System. Springer, Cham. https://doi.org/10.1007/978-3-031-40524-2_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-40524-2_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-40523-5

  • Online ISBN: 978-3-031-40524-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation